CODEXIS INC

Codexis Inc. specializes in the research and development of specialized enzymatic systems for applications in physical, engineering, and life sciences, with a demonstrated focus on acylase enzyme panels and biocatalytic process development. Their technical expertise lies in enzyme engineering, protein optimization, and high-throughput screening platforms that enable the design of bespoke biocatalysts for industrial and defense-related applications. The company leverages proprietary molecular evolution and computational biology tools to tailor enzyme performance for specificity, stability, and efficiency under demanding operational conditions, positioning them as a niche provider of engineered biocatalysts for precision chemical synthesis and process intensification. Their work supports advanced manufacturing and mission-critical biochemical workflows requiring high-purity, low-waste reaction pathways. Codexis has delivered research and development services to the Department of Defense, where their enzymatic panel development likely supports defense-relevant applications such as chemical sensing, decontamination, or biosynthetic logistics. The nature of the awarded work suggests a partnership centered on solving complex biochemical challenges requiring tailored enzyme solutions, indicating a capability to operate within stringent defense R&D frameworks. The company’s primary industry focus is on NAICS 541715—research and development in the physical, engineering, and life sciences—where they apply biotechnology to engineer functional proteins for non-biotech applications, distinguishing themselves from traditional biotech firms by targeting industrial and defense-oriented outcomes. Their market positioning is that of a precision biocatalyst developer serving high-value, low-volume sectors requiring customized enzyme solutions. Codexis Inc. is a privately held entity headquartered in Redwood City, California, with no public government certifications on record. The company maintains a focused geographic footprint centered in the San Francisco Bay Area’s biotech corridor, leveraging regional scientific infrastructure to support federal and defense innovation programs.